FierceBiotech ٢٢ أبريل ٢٠٢٦ Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
FierceBiotech ٢١ أبريل ٢٠٢٦ In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
FierceBiotech ١٧ أبريل ٢٠٢٦ Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
FierceBiotech ٢٥ مارس ٢٠٢٦ Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
FierceBiotech ٦ مارس ٢٠٢٦ Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal
FierceBiotech ١٢ فبراير ٢٠٢٦ Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma
FierceBiotech ١٠ فبراير ٢٠٢٦ Merck teams up with British medtech to boost vaginal therapeutics delivery system
FierceBiotech ١٩ ديسمبر ٢٠٢٥ Merck turns down option to Evaxion's gonorrhea vaccine, prompting Danish biotech to seek other partners
FierceBiotech ٩ ديسمبر ٢٠٢٥ ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap